SP70 could be used as a valuable biomarker for HCC, and a combination of SP70 with AFP enhances diagnostic efficiency compared to individual biomarkers and a combination of AFP and PIVKA-II. This evidence concerns the gene AFP and hepatocellular carcinoma.